{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:48:03Z","timestamp":1764510483860},"reference-count":11,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive tumor characterized by skin and\/or marrow infiltration by CD4+ CD56+ cells. Historically, the tumor was variably thought to arise from either monocytes, T cells or NK cells giving rise to terms such as CD4+\/CD56+ acute monoblastic leukemia, primary cutaneous CD4+\/CD56+ hematodermic tumor and blastic NK-cell lymphoma. Whilst considerable progress has been made in understanding the histogenesis, the best modality of treatment remains to be defined. We are therefore reporting this case which was successfully treated with a T-deplete allogeneic transplant and the patient is currently alive and in remission 4 years post transplant.<\/jats:p>","DOI":"10.4081\/hr.2014.5119","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T15:13:25Z","timestamp":1391008405000},"page":"5119","source":"Crossref","is-referenced-by-count":4,"title":["Reduced Intensity Allogeneic Stem Cell Transplant for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm"],"prefix":"10.3390","volume":"6","author":[{"given":"Anand","family":"Lokare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Nikolousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbignieuw","family":"Rudzki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhuvan","family":"Kishore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don","family":"Milligan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shankara","family":"Paneesha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1309\/FY6PK436NBK0RYD4","article-title":"CD4+\/CD56+ hematodermic tumor. The features of an evolving entity and its relationship to dendritic cells","volume":"127","author":"Herling","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1182\/blood.V99.11.4154","article-title":"CD4+, CD56+ DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique","volume":"99","author":"Leroux","year":"2002","journal-title":"Blood"},{"key":"ref3","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Faceheti","year":"2008"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1182\/blood-2002-10-3297","article-title":"TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin","volume":"101","author":"Herling","year":"2003","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/hon.2023","article-title":"Posttransplant lymphoproliferative disease of donor origin,following haematopoietic stem cell transplantation in a patient with blastic plasmacytoid dendritic cell neoplasm","volume":"30","author":"Piccin","year":"2012","journal-title":"Hematol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V99.5.1556","article-title":"Clinical and biologic features of CD4(+)CD56(+) malignancies","volume":"99","author":"Feuillard","year":"2002","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1309\/GJWNPD8HU5MAJ837","article-title":"Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review","volume":"123","author":"Petrella","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/01.pas.0000172194.32918.5c","article-title":"CD4(+) CD56(+) lineage\u2013negative malignancies are rare tumors of plasmacytoid dendritic cells","volume":"29","author":"Reichard","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bmt.1704215","article-title":"What is CD4+CD56+ malignancy and how should it be treated?","volume":"32","author":"Reimer","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"E140","DOI":"10.1002\/pbc.24622","article-title":"Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: a case report and review of literature","volume":"60","author":"Sakashita","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/01.tp.0000286098.28481.7d","article-title":"Successful non-myeloablative allogeneic HLA-identical stem cell transplantation for CD4\/CD56 positive acute leukemia","volume":"84","author":"Amor","year":"2007","journal-title":"Transplantation"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pagepress.org\/journals\/index.php\/hr\/article\/viewFile\/5119\/4207","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.mdpi.com\/2038-8330\/6\/1\/5119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T06:53:00Z","timestamp":1645599180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/6\/1\/5119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1]]}},"alternative-id":["hr.2014.5119"],"URL":"https:\/\/doi.org\/10.4081\/hr.2014.5119","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]}}}